MET and renal cell adenocarcinoma: These genes are commonly mutated in RCC tumors (e.g., VHL in ccRCC or MET in papillary RCC), and some of them possess prognostic potential based on the previous large-scale genomic studies [6,30,31] (Figure 2A).